Symptoms are usually sudden in onset and self-limiting, most often resolving within 2 weeks. IVIG therapy is the primary treatment. Additionally,<unk>  is an American Society for Apheresis Category III indication for plasmapheresis.
Post-transfusion purpura
Nonthrombocytopenic purpura
Transfusion-dependent anemia
Venom-induced consumption coagulopathy
Acute hemolytic transfusion reaction
Heparin-induced thrombocytopenia
Hyperviscosity syndrome
Thrombocytopenic purpura